Metabolic Modeling Predicts Unique Drug Targets in the Lyme Disease Pathogen Borrelia burgdorferi – Tufts University School of Medicine’s Peter Gwynne, PhD
Please join us for our February Levy CIMAR Science Lunch presented by Lyme disease expert Peter Gwynne, PhD, a research assistant professor at the Tufts University School of Medicine and Director for Translational Research at the Tufts University Lyme Disease Initiative. He will present on “Metabolic Modeling Predicts Unique Drug Targets in the Lyme Disease Pathogen Borrelia burgdorferi.”
Dr. Gwynne is interested in Borrelia burgdorferi, which causes Lyme disease, and the molecular mechanisms the bacterium uses to transition between different hosts such as ticks, mice, and humans. Dr. Gwynne’s research aims to exploit these unique metabolic interactions to design targeted drugs for Lyme disease.